In a xenograft model, intraperitoneal (i.p.)injection of ANGII significantly increases the tumorigenicity and metastasis of ovarian cancer cells, whereas an AGTR1 antagonist, losartan, suppresses this effect. This evidence concerns the gene AGTR1 and ovarian cancer.